← Back to catalogue

Lyphochek

FDA UDI

Class I (US FDA UDI)

by Bio-Rad Laboratories

Identity

Trade Name
Lyphochek FDA UDI
Generic Name
Benzodiazepine group IVD, control FDA UDI
Device Name
Lyphochek Benzo/TCA Control- Set B Level 1 (A human serum assayed benzodiazepines and TCA control.) FDA UDI
Model / Reference
663 FDA UDI
Description
Lyphochek Benzo/TCA Control- Set B Level 1 (A human serum assayed benzodiazepines and TCA control.) FDA UDI

Identifiers

Catalog Number
663 FDA UDI
Primary DI / UDI-DI
00847661000594 FDA UDI
510(k) Number
K955153 FDA UDI
FDA Product Code
DIF FDA UDI
GMDN Term
Benzodiazepine group IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.3280 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Benzodiazepine group IVD, controlTricyclic antidepressant IVD, control

Lyphochek by Bio-Rad Laboratories — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Tricyclic antidepressant IVD, control.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 05cabdb5-a57a-4122-b428-fdd59028b3ec 37 fields · synced Jun 8, 2026